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MicroRNA hsa-miR-135b Regulates Mineralization 
in Osteogenic Differentiation of Human Unrestricted 
Somatic Stem Cells
Aneta M. Schaap-Oziemlak,1 Reinier A. Raymakers,2 Saskia M. Bergevoet,1 Christian Gilissen,3 
Bastiaan J.H. Jansen,4 Gosse J. Adema,4 Gesine Kögler,5 Carlos le Sage,6 Reuven Agami,6 
Bert A. van der Reijden,1 and Joop H. Jansen1
Unrestricted somatic stem cells (USSCs) have been recently identifi ed in human umbilical cord blood and have 
been shown to differentiate into lineages representing all 3 germ layers. To characterize microRNAs that may 
regulate osteogenic differentiation of USSCs, we carried out expression analysis for 157 microRNAs using quan-
titative RT-PCR before and after osteogenic induction (t = 0.5, 24, 72, 168, 216 h). Three microRNAs, hsa-miR-135b, 
hsa-miR-224, and hsa-miR-31, were consistently down-regulated during osteogenesis of USSC line 1. Hsa-miR-
135b was shown to be the most profoundly down-regulated in osteogenesis of USSC line 1 and further confi rmed 
to be down-regulated in the osteogenic differentiation of 2 additional USSC lines. Function of hsa-miR-135b in 
osteogenesis of USSCs was examined by retroviral overexpression, which resulted in an evident decreased min-
eralization, indicating that hsa-miR-135b down-regulation is functionally important for full osteogenic differ-
entiation of USSCs. MicroRNAs have been shown to regulate negatively expression of their target gene(s). To 
identify putative targets of hsa-miR-135b, we performed cDNA microarray expression analysis. We selected in 
total 10 transcripts that were down-regulated (≥2-fold) in response to hsa-miR-135b overexpression at day 7 and 
day 9 of osteogenic differentiation. The function of most of these targets in human osteogenesis is unknown and 
requires further investigation. Markedly, quantitative RT-PCR data showed decreased expression of osteogenic 
markers IBSP and Osterix, both known to be involved in bone mineralization, in osteogenesis of USSCs that 
overexpress hsa-miR-135b. This fi nding suggests that hsa-miR-135b may control osteoblastic differentiation of 
USSCs by regulating expression of bone-related genes.
Introduction
MicroRNAs represent a large and expanding class of small, single-stranded, non-coding RNAs found 
in both the plant and animal kingdoms. The 19–25 nucle-
otides long mature microRNAs are generated from en-
dogenous double-stranded transcripts containing hairpin 
structures by the action of multiprotein complexes in-
volving RNAse-III-like endonucleases (Drosha and Dicer) 
(ref. 1; reviewed in [2,3]). MicroRNAs have been shown 
to play roles in diverse biological processes, including 
proliferation, differentiation, and apoptosis (reviewed in 
ref. [4–6]). MicroRNAs exert their biological function by 
negative regulation of the expression of target genes, either 
by mRNA degradation and/or translational repression, 
depending respectively on perfect or imperfect comple-
mentarity of the mature microRNA sequence to the 3′- or 
5′-UTRs of the target microRNAs (ref. 7; reviewed in  ref. 
[6,8]). To identify possible target mRNAs for any given 
microRNA, publically available computational prediction 
al go rithms such as miRBase (ref. 9; www.microrna.sanger.
ac .uk), PicTar (ref. 10; www.pictar.bio.nyu.edu), DIANA-
microT (ref. 11; www.diana.pcbi.upenn.edu/cgi-bin/micro_t.
cgi), and TargetScanS (ref. 12; www.genes.mit.edu/tscan/ 
targetscanS) have been developed.
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St. Louis, MO). To quantify ALP activity, pNPP (p-nitrophe-
nylphosphate) hydrolysis method was applied, followed by 
reading the absorbance at 405 nm in duplicate (empty vec-
tor and overexpressing hsa-miR-135b) in 96-well format. A 
background absorbance of empty wells was subtracted from 
the absorbance of the samples.
To test mineralization, Alizarin Red S (ARS) staining 
was performed, where cells were fi rst washed twice with 
PBS, then fi xed with 4% paraformaldehyde, washed with 
water, and incubated with ARS solution (1%, pH = 4.1; 
Sigma-Aldrich, Buchs, UK) for 5 min at room temperature, 
followed by 3 washings with water while gently shaking for 
5 min.
Alizarin Red S quantifi cation
Quantifi cation of the mineralization at different time 
points during USSCs osteogenesis was based on adapted 
protocol described by Gregory et al. [18]. In brief, for quan-
tifi cation ARS staining (40 mM solution, pH = 4.1) was 
performed on USSCs and differentiated (osteogenic; ini-
tial seeding density 16,000 cells/cm2) monolayers in 6-well 
plates for 30 min at room temperature with gentle shaking, 
followed by washing with water and storage of plates at 
-20°C before ARS quantifi cation. ARS was extracted from 
the stained monolayer by incubation with 10% (v/v) acetic 
acid (0.8 mL/well; Sigma-Aldrich, St. Louis, MO) while shak-
ing, followed by scraping the cells and transfer of the slurry 
to a 1.5-mL Eppendorf tube and overlaying it with mineral 
oil (Sigma-Aldrich). The slurry was then heated to 85°C 
for 10 min, transferred on ice, and centrifuged at 15,000g 
for 15 min at room temperature. Next, 0.2 mL ammonium 
hydroxide (10% (v/v); Sigma-Aldrich) was added to 0.5 mL 
of supernatant to neutralize the acid. The extracted ARS was 
quantifi ed by reading the absorbance at 405 nm in duplicate 
(empty vector) or quadruplicate (overexpressing hsa-miR-
135b) of supernatant aliquots (150 μL) in 96-well format. A 
background absorbance of empty wells was subtracted from 
the absorbance of the samples.
Retroviral vectors and virus production
Phoenix amphotrophic (Φ-NX-A) virus producer cell 
line (a gift from Dr. GP Nolan, Stanford University Medical 
Center, Stanford, CA) was used to generate retroviral vec-
tor particles carrying constructs encoding microRNA 
minigenes or control vectors (empty miR-Vec-Ctrl and miR-
Vec-YFP). All retroviral constructs used in this study were 
kindly provided by Dr. Reuven Agami (The Netherlands 
Cancer Institute, Amsterdam), and their generation was 
described in detail by Voorhoeve et al. [19]. In brief, miR-
Vec-Ctrl and microRNA minigene containing vectors were 
based on the pMSCV-puro (Clontech, Mountain View, CA) 
backbone, where PGK-promoter and puromycin-resistant 
gene were replaced, respectively, by CMV promoter and 
the blasticidin-resistant gene [19]. The miR-Vec-EYFP, in 
which the blasticidin-resistant gene was replaced by EYFP 
(pEYFP-N1; Clontech), was used as a control to test trans-
duction effi ciency in USSCs. The miR-Vec-Ctrl was included 
as an empty vector control in hsa-miR-135b overexpression 
experiments.
Transfection of all retroviral constructs into Φ-NX-A pro-
ducer line was performed by using the calcium phosphate 
To determine the role of microRNAs in the regulation 
of osteogenic differentiation of human pluripotent stem 
cells, we investigated the osteogenic differentiation poten-
tial of the recently described unrestricted somatic stem cells 
(USSCs), derived from umbilical cord blood [13]. This neona-
tal type of stem cells with spindle-shaped morphology has 
been shown to give rise to different lineages including oste-
ogenic, chondrogenic, adipogenic, hepatogenic, neurogenic, 
and hematopoietic [13–15].
Osteogenesis is described as a well-orchestrated mul-
tistep process, in which multipotent stem cells give rise to 
committed osteoprogenitors that in turn differentiate into 
osteoblasts. These undergo further maturation by produc-
tion of bone matrix proteins, followed by the extracellular 
matrix (ECM) mineralization (ref. [16]; reviewed in ref. [17]). 
Molecular pathways underlying this differentiation program 
have not yet been entirely examined. Specifi cally, a thorough 
expression analysis of microRNAs combined with the exper-
imental examination of their function and target genes in the 
osteogenesis of USSCs has never been described. Functional 
validation of most differentially expressed microRNA in the 
osteogenic differentiation of USSCs is important to under-
stand the regulatory mechanisms of microRNA(s) in the os-
teogenic differentiation of stem cells.
Materials and Methods
Generation and culture of USSC lines
USSCs used in all experiments were generated from fresh 
umbilical cord blood as described before [13]. In brief, the 
mononuclear fraction of cells obtained by a Ficoll (density 
1.077 g/cm3; Ficoll-paque 1077; GE Healthcare, Uppsala, 
Sweden) gradient centrifugation was plated for 2 weeks in 
USSC proliferation medium (DMEM-LG [Lonza, Verviers, 
Belgium] supplemented with preselected FBS (30%; 
[HyClone, South Logan, Utah]), penicillin (100 U/mL) and 
streptomycin (0.1 mg/mL; [MP Biomedicals Inc., Cleveland, 
OH]), ultraglutamine (2 mM; [Cambrex, Verviers, Belgium]), 
and dexamethasone (10−7 M; [Sigma-Aldrich Inc., St. Louis, 
MO])). After 2 weeks, cells were cultured for an additional 
2–4 weeks without dexamethasone until adherent colonies 
were observed. Expansion of these colonies was performed 
by 5 subsequent passages, followed by freezing the cells and 
thereby establishing the USSC lines.
USSC lines were cultured in proliferation medium at 37°C 
and 5% CO2 in a humidifi ed atmosphere. At 70% confl uency, 
cells were trypsinized and replated in the volume ratio 1:3.
Osteogenic differentiation of USSCs in vitro
USSCs (passages 9–13), derived from 3 different donors, 
were plated at a cell density of 8,000 or 16,000 cells/cm2 
in 24-well plates or 6-well plates (as indicated in text). At 
70% confl uency, proliferation medium was replaced by 
osteogenic medium containing dexamethasone (10−7 M), 
ascorbic acid (50 μM; Sigma-Aldrich, St. Louis, MO), and 
β-glycerophosphate (10 mM; MP Biomedicals Inc., Solon, 
OH) as previously described [13]. USSCs were differenti-
ated for 14 days. Alkaline phosphatase (ALP) activity was 
tested at different time points (0, 3, 7, 9, and 14 days) dur-
ing USSCs osteogenesis by performing ALP staining using 
as substrate a naphthol AS-MX phosphate (Sigma-Aldrich, 
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BGLAP, forward, 5′-AGCAAAGGTGCAGCCTTTGT-3′, 
reverse, 5′-GCGCCTGGGTCTCTTCACT-3′ (63 bp); OSX/
SP7 (osterix), forward, 5′-GTGGGCAGCTAGAAGG
GAGT-3′, reverse, 5′-AATTAGGGCAGTCGCAGGA-3′ (114 
bp); IBSP (bone sialoprotein), forward, 5′-CATAAACGG
CACCAGTACCAA-3′, reverse, 5′-CTCCATTGTCTCCT 
C CGCT-3′ (71 bp). For a quantitative analysis of expression 
level of mature microRNAs, the microRNA human panel 
expression assay (Early Access Kit PN4365381; Applied 
Biosystems; Supplementary Table 1; Supplementary mate ri-
als are available online at www.liebertonline.com/scd) was 
applied. RNA input was normalized by GAPDH RT-PCR 
(TaqMan Gene Expression Assay for human GAPDH; Ap -
plied Bio systems). First each microRNA-specifi c RT reaction 
with a specifi c stem-loop RT primer was performed using 
10 ng of total RNA, followed by a real-time RT-PCR with 
1.3 μL of RT-product, microRNA-specifi c tailed forward 
primer, and nonspecifi c microRNA reverse primer as pre-
viously  described [20].
Microarray data generation and analysis
For microarray experiments, total RNA from 2 undiffer-
entiated USSCs (line 1; passages 11 and 12) and differenti-
ated from day 7 and day 9 of osteogenesis, including empty 
vector-transduced- and hsa-miR-135b-overexpressing 
USSCs, was isolated using the RNeasy Mini kit (Qiagen) 
according to the manufacturer’s protocol. Quality of RNA 
was tested using the Agilent 2100 Bioanalyzer. One hun-
dred nanograms of total RNA from each sample were used 
for cDNA amplifi cation and 5.5 μg of amplifi ed cDNA of 
each sample was applied to perform hybridizations on the 
GeneChip Human Exon 1.0 ST Array (Affymetrix) according 
to the Affymetrix GeneChip Expression Analysis Technical 
Manual (GeneChip® Whole Transcript (WT) Sense Target 
Labeling Assay Manual P/N 701880 Rev. 4, www.affymetrix.
com). This human exon array contains >1,400,000 probe sets 
with an average of 4 probes per exon and about 40 probes 
per gene (Affymetrix Technical Note, www.affymetrix.com/
support/technical/datasheets/exon_arraydesign_datasheet.
pdf, Part No. 702026 Rev. 1). Genomic positions of the probe 
sets for each transcript (so called transcript cluster ID) given 
in the article can be found online by using The NetAffx™ 
Analysis Center (www.affymetrix.com/analysis/index.
affx).
Gene level expression data were calculated for the CORE 
transcripts using Affymetrix Expression Console software 
using sketch-quantile normalization, PM-GCBG back-
ground correction, and summarization with the PLIER 
algorithm. Pearson’s correlation was used to check corre-
spondence between the samples. Data were then imported 
into GeneSpring GX 7.3, where per array the expression of 
each transcript was normalized to the median. Genes with a 
≥2-fold change between the samples were selected.
Statistical analysis
All included data are presented as a mean with standard 
error shown. For determining P value, unpaired (different 
USSC lines) or paired (the same USSC line) Student’s t-test 
for 2 tails was performed. P value ≤0.05 (marked as “a”) was 
defi ned as statistically signifi cant.
method. Briefl y, 24 h prior transfection Φ-NX-A cells were 
plated at 2.8 × 106 cells/75 cm2. Sixteen hours after transfec-
tion, the Φ-NX-A culture medium [DMEM high-glucose me-
dium (Gibco, Paisley, Scotland, UK), supplemented with FCS 
(10%; Gibco), penicillin (100 U/mL), streptomycin (0.1 mg/
mL; MP Biomedicals Inc., Solon, OH), and l-glutamine (200 
mM; MP Biomedicals Inc.)], was refreshed. Twenty-four and 
48 hrs after medium refreshment, the medium containing 
retroviral particles was collected, fi ltered through a sterile 
0.45-μm pore size fi lter (Whatman GmbH, Dassel, Germany), 
and stored as aliquots at –80°C.
USSCs retroviral transduction
Before retroviral transduction, 35-mm Petri dishes were 
coated with retronectin (Takara Bio Inc., Otsu, Shiga, Japan). 
0.4 × 106 USSCs (line 1; passages 8 and 9) after 1-h incuba-
tion with viral supernatant at 37°C were plated into virus-
preloaded retronectin-coated 35-mm Petri dishes (0.2 × 106 
USSCs/dish) and further incubated with the virus for 24–48 
h at 37°C and 5% CO2 in a humidifi ed atmosphere. Next, 
USSCs were washed twice with Hank’s balanced salt so-
lution (HBBS; Lonza, Verviers, Belgium) and after 24–48 h 
transduced USSCs were selected by culturing them in USSC 
proliferation medium in the presence of blasticidin (5 μg/
mL; Invitrogen Corporation, Carlsbad, CA) for 7 days. In 
parallel, to test the blasticidin toxicity, a selection control 
(not transduced USSCs) was included, where 100% of USSCs 
died after 1–2 days of exposure to the blasticidin. After blas-
ticidin selection, transduced USSCs were expanded for 2–3 
days prior to osteogenic differentiation.
Transduction effi ciency of USSCs with usage of the miR-
Vec-EYFP construct, measured by EYFP expression by fl ow 
cytometry (Beckman Coulter Cytomics FC 5000; Beckman 
Coulter, Miami, FL), was in a range of 12%–22%.
Total RNA isolation
Total RNA was isolated from undifferentiated and dif-
ferentiated USSCs either by using the RNA-Bee isolation 
kit (Iso-Tex Diagnostics, Friendswood, TX) or the miR-
Vana isolation kit (Ambion Inc., Austin, TX) according to 
the manufacturer’s protocols. For harvesting, an adherent 
layer of USSCs was fi rst washed with PBS, followed by addi-
tion of lysis buffer and scraping. The RNA concentration 
was measured by ND-1000 spectrophotometer (NanoDrop 
Technologies, Wilmington, DE) and the quality of RNA was 
estimated by electrophoresis based on the integrity of rRNA 
(18S and 28S).
Expression analysis
cDNAs, used as templates in RT-PCR, from undifferenti-
ated and differentiated USSCs were obtained by performing 
a RT reaction, in which 1 μg of total RNA was used. For a rela-
tive (normalized to GAPDH) expression analysis, a real-time 
reverse transcription (RT)-PCR was performed (ABI/PRISM 
7700 Sequence Detection System; ABI/PE, Foster City, CA) 
by using SYBR Green PCR master mix (Applied Biosystems, 
Foster City, CA) and primers specifi c for: RUNX2/CBFA1, 
forward, 5′-GCAAGGTTCAACGATCTGAGA-3′, reverse, 
5′-TCCCCGAGGTCCATCTACTG-3′ (141 bp); osteocalcin/
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the repression of genes essential for driving the osteogenic 
differentiation program [22]. Therefore, we decided to inves-
tigate the function in the osteogenic differentiation of USSCs 
of most down-regulated microRNA, hsa-miR-135b. We retro-
virally overexpressed hsa-miR-135b in USSCs and induced 
osteogenic differentiation. Overexpression of hsa-miR-135b 
(>500-fold) was confi rmed by real-time RT-PCR both in un-
differentiated USSCs and osteogenic cells (Fig. 2B). A pro-
found decrease in ARS staining was observed at day 7 during 
the osteogenic differentiation of USSCs overexpressing hsa-
miR-135b compared to empty vector-transduced USSCs (Fig. 
2A). In addition, the quantitative measurement of the ARS 
staining at different time points during osteogenesis showed 
reduced ARS staining by 2.7-fold at day 7, followed by 1.5-
fold at day 8, 1.7-fold at day 9, 1.6-fold at day 12, and 2.2-fold 
at day 14 relative to the empty vector control (Fig. 2C). In 
parallel to the ARS staining, we performed ALP staining 
during the osteogenic differentiation but we did not observe 
any signifi cant changes in the ALP activity of hsa-miR-135-
b-overexpressing USSCs compared to empty vector control-
transduced USSCs (Supplementary Fig. 1).
Discussion
In this study, we showed that among 157 human microR-
NAs tested, hsa-miR-135b was the most profoundly down-
regulated microRNA during osteogenesis of USSC line 1. 
This down-regulation was further confi rmed in osteogenesis 
of 2 additional independent USSC lines. A recently pub-
lished microRNA expression profi ling of osteogenesis of 
murine mesenchymal C2C12 cells showed that most (88%) 
of the differentially expressed microRNAs in response to 
BMP2-induced osteogenesis were down-regulated [22]. 
These results are consistent with the osteogenic signature of 
USSCs presented in our study since we found mainly down-
regulated microRNAs during the osteogenesis of USSCs. 
In addition, one of the functionally important microRNAs, 
down-regulated in C2C12 osteogenesis, appeared to be 
miR-135a [22], a family member of miR-135b. Importantly, 
regarding sequence conservation, both miR-135a and miR-
135b, are identical between human and mouse.
Notably, we did not fi nd any microRNAs that were con-
sistently up-regulated during the osteogenic differentiation 
of USSCs including let-7a that has been shown previously to 
be up-regulated (at day 7) in this process [23]. Furthermore, 
the down-regulation of hsa-miR-135b during osteogenesis 
observed in this study was not observed in the study by 
Landgraf et al., in which hsa-miR-135b was undetectable 
before and after the osteogenic induction. These differences 
in the microRNA expression profi ling between our data and 
the data by Landgraf et al. may be explained by the use of 
various detection methods, which differ both in sensitivity 
and specifi city.
Results
Expression profi le of microRNAs in osteogenic 
differentiation of USSCs
Culturing of USSC lines in low-glucose-containing me-
dium in the presence of osteogenic inductive factors (dexa-
methasone, β-glycerophosphate, and ascorbic acid) led to a 
typical osteogenic phenotype: a cuboidal cell morphology, 
characteristic for osteoblasts, increased activity of the ALP, 
and mineralization of the ECM (reviewed in ref. [17,21]). An 
increase in both the number of ALP-positive (blue) cells and 
ALP activity per cell was observed starting from day 3 until 
day 7 of osteogenesis, reaching a peak of the ALP activity, 
characteristic for the osteoblastic stage, at day 7 (Fig. 1A). 
Following day 9 of the osteogenic differentiation of USSCs, 
the ALP activity decreased up to day 14. The degree of min-
eralization was evaluated based on ARS staining and exam-
ined at different time points during osteogenesis: days 0, 3, 7, 
9, and 14 (Fig. 1B). At day 7 the fi rst mineral deposits appeared 
(orange staining), followed by more robust mineralization at 
day 9 and day 14 of differentiation. Furthermore, a signifi -
cantly elevated expression of osteogenic markers such as ALP, 
Runx2, collagen type I, and osteocalcin confi rmed osteogenic 
differentiation potential of the USSCs (data not shown).
To identify microRNAs involved in the regulation of the 
osteogenic differentiation of USSCs, we measured the ex-
pression of 157 microRNAs by a real-time RT-PCR at differ-
ent time points of osteogenesis (0, 0.5, 24, 72, 168, and 216 h) 
of USSC line 1. We found that 3 microRNAs, hsa-miR-135b, 
hsa-miR-224, and hsa-miR-31, were consistently down-reg-
ulated between day 3 and day 9 of the osteogenic differen-
tiation of USSC line 1. The expression level of hsa-miR-135b 
was decreased 100-fold at day 9 compared to undifferenti-
ated USSCs and expression of hsa-miR-31 and hsa-miR-224 
declined at day 9, respectively, by a factor 14.3 and 20 (Fig. 
1C). Since hsa-miR-135b was the most profoundly down-
regulated microRNA in osteogenesis of USSC line 1, we ex-
amined its expression during osteogenesis in 2 additional 
USSC lines, derived from 2 different donors. Similarly to 
USSC line 1, we observed a decrease in the expression level 
of this microRNA during the osteogenic differentiation of 
USSC lines 2 and 3, albeit to a lower degree (data not shown). 
Combining the expression data of 3 biological replicates of 
hsa-mir-135b in osteogenesis, a 4.2-fold and a 2.8-fold de-
creased expression of this microRNA, respectively, at day 7 
and day 9 of the osteogenic differentiation was observed.
Function of hsa-miR-135b in osteogenic 
differentiation of USSCs
It has been shown that inhibition of microRNA(s) during 
osteogenic differentiation appears to be necessary to release 
FIG. 1. Osteogenic differentiation of unrestricted somatic stem cells (USSCs) and differentially expressed microRNAs. (A) 
ALP (alkaline phosphatase) assay performed during different time points in USSCs osteogenesis, showing an increase in ALP 
activity (blue) with a peak at day 7; magnifi cation 5×. (B) Mineralization was detected by performing Alizarin Red S (ARS) 
staining at different time points in osteogenesis; magnifi cation 5×. (C) Expression of microRNAs in osteogenesis of USSC line 
1 shown as a logarithmic graph with indicated relative (to t = 0) expression level with standard error. Data calculated based 
on averages of 2 amplifi cations, followed by calculating relative to t = 0 expression per each time point. Statistically signifi cant 
data, relative to t = 0 shown with P value ≤0.05 (marked as “a”). Each photo in (A) and (B) represents two-third of the well.
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the same time-course experiment. In contrast to the expres-
sion of BGLAP and RUNX2, which remained unchanged, 
the expression of bone sialoprotein (IBSP) and OSX was 
decreased at day 7 by 7.18-fold and 3.18-fold, respectively, 
and at day 9 by 3.56-fold and 1.55-fold, respectively, in hsa-
miR-135b-overexpressing USSCs compared to empty vec-
tor-transduced USSCs (Fig. 3). Though both IBSP and OSX 
do not represent direct computational target genes of hsa-
miR-135b, they have been shown to be functionally impor-
tant in ossifi cation. The role of IBSP particularly in de novo 
bone mineralization has been reported before [32,33], and 
strongly suggests that its decreased expression level at day 7 
and day 9 in hsa-miR-135b-overexpressing USSCs might be 
responsible for the observed decline in the mineralization.
To further dissect the possible mechanism(s) of hsa-miR-
135b action in USSCs osteogenesis, we decided to identify 
putative target genes of hsa-miR-135b. At this point, it is im-
portant to underline that microRNAs may affect expression of 
their targets both at the transcriptional as well as at the trans-
lational level (reviewed in ref. [35,36]). In addition, although 
most of the parameters used by target prediction algorithms 
are similar (complementarity of 5′ sequence of microRNA to 
3′ UTR sequences of target mRNA(s), phylogenetic sequence 
conservation of 3′ UTRs or mRNA(s) target multiplicity), each 
of these programs varies substantially by types of predicted 
targets, the numbers of covered genomes, followed by differ-
ences in percentages of false-positive rates (reviewed in ref. 
[8]). Therefore, an experimental validation of computational 
mRNA targets for specifi c microRNA is always necessary. In 
our study, the selection of hsa-miR-135b targets was based on 
the changes at the transcriptional level of the target gene(s). 
First, we performed a microarray-based gene expression 
analysis of 2 undifferentiated USSCs: empty vector-transduced 
USSCs and hsa-miR-135b-overexpressing USSCs, followed by 
a microarray-based gene expression analysis of differentiated 
USSCs at day 7 and day 9 of osteogenesis. Taking into account 
the time kinetics of hsa-miR-135b down-regulation in USSCs 
osteogenesis, we selected in total 10 transcripts that were 
down-regulated (≥2-fold) in response to the hsa-miR-135b 
overexpression at day 7 and day 9 of osteogenic differentia-
tion (Supplementary Table 2). These genes did not appear to 
be in silico targets as they were not identifi ed by miRBase or 
TargetScan. The function of 7 of these target genes, which in-
cluded IL31, KCQIDN, MGC23284, REX01L1, CRIP1, CKB, and 
LHB, in human osteogenesis remains unknown and should 
be further investigated. The other 2 experimentally identifi ed 
Considering the fact that the most signifi cant down-reg-
ulation of hsa-miR-135b was observed during the osteogenic 
differentiation of all 3 USSC lines between day 7 and day 9 
may point to an important role of hsa-miR-135b in minerali-
zation. Indeed, in our study overexpression of hsa-miR-135b 
in USSCs osteogenesis led to an evident decrease (2-fold 
in average) in the level of ARS staining within this partic-
ular time frame of differentiation. Furthermore, based on 
our data showing a decrease in mineralization as a result 
of deregulated hsa-miR-135b expression levels, and data of 
others showing a robust inhibition of mineralization upon 
knockdown of the microRNA-processing enzyme Dicer 
using human mesenchymal stem cells [24], the proper 
expression level of microRNA(s) during osteogenesis is criti-
cal for the full osteogenic differentiation potential.
The lack of any signifi cant changes in the ALP activ-
ity during the osteogenic differentiation of hsa-miR-135b-
overexpressing USSCs suggests that the induction of this 
enzyme alone, known also as TNAP (tissue-nonspecifi c ALP; 
reviewed in ref. [17]), is not suffi cient for the mineralization 
process. This observation might be in line with a debatable 
solitary role of TNAP in the mineral deposition (reviewed 
in ref. [25–30]). From mouse knockout studies, it has been 
shown that the TNAP defi ciency results in a normal embry-
onic skeletal development and poor mineralization at post-
natal stages [27,31], suggesting that TNAP does not play an 
essential role in the initiation of mineralization but is rather 
important for its maintenance.
The down-regulation of hsa-miR-135b during USSCs 
osteogenesis might also be compatible with a role in mainte-
nance of the stemness of USSCs. Interestingly, recently pub-
lished data from embryonic stem (ES) cells have shown a 
conserved (both in mouse and human) binding of Oct4, one 
of the key regulators of self-renewal and pluripotency of ES 
cells, at the promoter of the miR-135b gene [27], suggesting 
that miR-135b gene is a direct target of Oct4 in ES cells.
The identifi cation of hsa-miR-135b helps to elucidate the 
basic regulatory network implicated in human osteogenic 
differentiation. Furthermore, to understand the molecular 
mechanism underlying hsa-miR-135b function in USSCs 
osteogenesis, we performed both an expression analysis 
of osteoblast markers such as osteocalcin (BGLAP), bone 
sialoprotein (IBSP), osterix (OSX), and RUNX2 by real-time 
RT-PCR, and a microarray analysis for undifferentiated and 
differentiated USSCs overexpressing hsa-miR-135b and 
empty vector control at days 0, 7, and 9 of osteogenesis in 
FIG. 2. Hsa-miR-135b overexpression in unrestricted somatic stem cells (USSCs) osteogenesis. (A) To monitor the mineral 
deposition, Alizarin Red S (ARS) staining was performed at indicated different time points during the osteogenic differen-
tiation of USSCs overexpressing hsa-miR-135b (bottom panel) and USSCs transduced with empty vector as a control (upper 
panel); magnifi cation 5× and each photo represents two-third of the well. The data shown here represent 2 separate differ-
entiation experiments that yielded similar results. (B) The expression of hsa-miR-135b during osteogenesis of USSCs (line 1) 
was measured by a real-time RT-PCR at indicated time points. The expression level of hsa-miR-135b in both untransduced 
USSCs and overexpressing hsa-miR-135b is represented by the absolute Ct values. Hsa-miR-135b = expression in untrans-
duced USSCs; OV (24 h) hsa-miR-135b = hsa-miR-135b-overexpressing USSCs (USSCs incubated with virus for 24 h); OV (48 
h) hsa-miR-135b = hsa-miR-135b-overexpressing USSCs (USSCs incubated with virus for 48 h). Data were calculated based 
on averages of 2 amplifi cations per each condition, with standard error shown. Statistically signifi cant data, relative to t = 0 
shown with P value ≤0.05 (marked as “a”). (C) Mineralization determined by a spectrophotometric measurement of extracted 
ARS dye at indicated time points. OS = USSCs induced toward osteogenic lineage; UN = USSCs cultured in undifferentiated 
condition; hsa-miR-135b = hsa-miR-135b-overexpressing USSCs. Data represent mean absorbance at 405 nm with standard 
error shown. Statistically signifi cant data, relative to t = 0 of each condition shown with P value ≤0.05 (marked as “a”).
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FIG. 3. Expression of osteoblastic markers during osteogenic differentiation of hsa-miR-135b-overexpressing unrestricted 
somatic stem cells (USSCs). A real-time RT-PCR analysis of RUNX2, bone sialoprotein (IBSP), Osteocalcin, and Osterix expression 
relative to GAPDH was performed at indicated time points. Light gray columns indicate empty vector-transduced USSCs 
(control) and dark gray columns hsa-miR-135b-overexpressing USSCs. Data represent mean of 2 amplifi cations per each con-
dition, with standard error shown. Statistically signifi cant data, relative to t = 0 shown with P value ≤0.05 (marked as “a”).
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